GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Haiyao Co Ltd (SZSE:000566) » Definitions » Risk Assessment

Hainan Haiyao Co (SZSE:000566) Risk Assessment


View and export this data going back to 1994. Start your Free Trial

What is Hainan Haiyao Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Hainan Haiyao Co is: High Risk: High uncertainty with risk-return tradeoff.


Competitive Comparison of Hainan Haiyao Co's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Haiyao Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Haiyao Co's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Haiyao Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Hainan Haiyao Co's Risk Assessment falls into.



Hainan Haiyao Co  (SZSE:000566) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Hainan Haiyao Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Hainan Haiyao Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Haiyao Co (SZSE:000566) Business Description

Traded in Other Exchanges
N/A
Address
No.192 Nanhai Avenue, Xiuying District, Haikou, Hainan, CHN, 570105
Hainan Haiyao Co Ltd is a China-based company engages in the research, development, manufacture, and sale of medicines and medical instrument. Its product includes cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company distributes its products in domestic market and to overseas market. Digital China Information Service Co Ltd is a China-based company principally engaged in software and information technology (IT) service industry. Its services include technical services, agricultural informatization, application software development, special financial equipment, and integrated solutions for the financial, government, enterprises, telecommunications, agriculture, and other industries.
Executives
Li Ri Meng Directors, executives
Bai Zhi Quan Directors, executives
Zhou Qing Guo Supervisors
Chen Yi Hong Directors, executives
Wang Wei Directors, executives
Ji Ping Executives
Xu Li Hong Directors, executives
Zhang Hui Executives
Wang Jun Hong Executives
Li Mi Sheng Executives
Feng Bai Chang Executives
Wang Gang Executives
Ceng Yu Ping Director

Hainan Haiyao Co (SZSE:000566) Headlines

No Headlines